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Abstract 
BACKGROUND: Latex allergy continues to be an increasingly serious 
occupational health problem in Taiwan, where it affects approximately 6.8% 
to 12% of health care workers. Contrasting with reports from western 
countries, Hev b1 and hevamine, and not Hev b3, 5 or 6.02, are the major 
latex allergens among health care workers in Taiwan. This study aimed at 
evaluating the allergenicity of 30 brands of commercially available medical 
latex gloves in Taiwan in 2007. 
METHODS: Residual Hev b1 and hevamine from the gloves were measured 
by inhibition enzyme-linked immunosorbent assay using polyclonal 
antibodies against purified recombinant Hev b1 and hevamine. The results 
were compared to those achieved with quantification of residual total 
extractable proteins and skin prick testing. 
RESULTS: The residual extractable protein levels in 30 medical gloves all 
conformed to United States Food and Drug Administration regulations. All 
the gloves except one yielded strong skin prick reactions in latex-allergic 
individuals. The only brand of gloves that consistently produced no skin 
prick reactions in latex-allergic individuals contained the lowest residual 
levels of Hev b1 (0.60 microg/g) and hevamine (0.07 microg/g). 
CONCLUSIONS: Our results suggest that the measurement of residual 
extractable total proteins is not sufficient to assess the allergenicity of latex 
gloves and that Hev b1 and hevamine may be used as indicator allergens in 
areas where they are major latex allergens, such as Taiwan. 
 
